AURA
Aura Biosciences Inc
6.20$
+2.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | +0.0% | -100.0% | – | – | -100.0% | – | – | – | – | – | – | |
| – | -19.0% | -5.6% | +2.3% | +0.0% | -7.0% | +0.0% | +3.1% | +0.0% | -300.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -145.7% | – | – | |
| – | +31.4% | -15.9% | -1.0% | +0.9% | +31.1% | +4.5% | -2.0% | -3.1% | -1.3% | +27.7% | +10.0% | – | |
| – | -11.0% | +16.8% | +11.8% | +5.3% | -11.7% | +4.0% | +0.7% | -0.1% | -6.8% | +29.3% | +150.8% | – | |
| – | +21.0% | -11.2% | +3.4% | +2.1% | +19.7% | +4.4% | -2.5% | -1.4% | -2.4% | +28.0% | +37.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +0.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -66.4% | -102.2% | – | -44.2% | -25.0% | +166.7% | -45.8% | -42.3% | -26.7% | +163.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.